Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"measurement"

Slides: 1–12 of 49
Add to tray Remove from tray

Considerations That Differ From Nonrandomized Studies

Presentation: Study Size Planning for Observational Comparative Effectiveness Research
Keywords: considerations | nonrandomized study | randomized controlled trial
Attributes of Good-Quality Studies. Design and conduct of study address risk of bias. Appropriate measurement of outcomes. Appropriate statistical and analytical methods. Low drop-out rates. Adequate reporting of statistical and analytical methods, drop-out rates and reasons, and outcomes (no reporting errors).
Add to tray Remove from tray

Attributes of Good-Quality Studies

Presentation: Assessing the Quality of Individual Studies
Keywords: quality | bias | outcome
Add to tray Remove from tray

Causal Models and the Structural Relationship of Variables (3 of 7)

Presentation: Covariate Selection for Observational Comparative Effectiveness Research
Keywords: causal models | intermediate variables
Add to tray Remove from tray

Proxy Confounders and Mismeasured and Unmeasured Confounders

Presentation: Covariate Selection for Observational Comparative Effectiveness Research
Keywords: proxy confounders | mismeasured and unmeasured confounders | sensitivity analysis
Add to tray Remove from tray

Conclusions

Presentation: Covariate Selection for Observational Comparative Effectiveness Research
Keywords: summary checklist | guidance | key considerations | covariate selection
Add to tray Remove from tray

Background: Diagnosis of Obstructive Sleep Apnea (2 of 3)

Presentation: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Keywords: background | diagnosis | polysomnography | monitor | sleep study | questionnaire | clinical prediction rules
Add to tray Remove from tray

Background: Diagnosis of Obstructive Sleep Apnea (3 of 3)

Presentation: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Keywords: AHI | apnea-hypopnea Index | background | diagnosis | measurement of severity | clinical features
Add to tray Remove from tray

Results From Evaluation of JIA Assessment Instruments (1 of 2)

Presentation: Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis
Keywords: active joint count | AJC | anti-rheumatic | antirheumatic | assessment | biologic DMARD | disease-modifying | DMARDs | JCA | JIA | JRA | juvenile rheumatoid arthritis | non-biologic DMARD | nonbiologic DMARD | parent assessment of well-being | PGA | PGW | physician global assessment | reliability | responsiveness | rheumatic | TNF-alpha blockers | validity | juvenile idiopathic arthritis
Add to tray Remove from tray

Results From Evaluation of JIA Assessment Instruments (2 of 2)

Presentation: Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatoid arthritis | JCA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | TNF-alpha blockers | biologic DMARD | nonbiologic DMARD | non-biologic DMARD | assessment | validity | reliability | responsiveness | active joint count | physician global assessment | parent assessment of well-being | AJC | PGA | PGW | CHAQ | CHq | PedsQL | PedsQl-RM
Add to tray Remove from tray

Knowledge Gaps and Future Research Needs

Presentation: Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis
Keywords: juvenile idiopathic arthritis | JIA | JRA | juvenile rheumatoid arthritis | JCA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | TNF-alpha blockers | biologic DMARD | nonbiologic DMARD | non-biologic DMARD
Add to tray Remove from tray

Adverse Effects of Interest in the Comparative Effectiveness Review

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | adverse effects
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | withdrawal | adverse events | adverse effects | certolizumab pegol | etanercept | rituximab | anakinra | infliximab
Pages: [1] 2 3 4 5 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364